Format

Send to

Choose Destination
See comment in PubMed Commons below
Br J Clin Pharmacol. 1975 Oct;2(5):437-42.

Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis.

Abstract

A clinical trial of phenylbutazone in high dose (300 mg daily) and low dose (50 mg daily) is presented. 2. By analysis of the data by different methods, significant differences in clinical efficacy were shown between the two therapeutic regimes. 3. A relationship between the clinical effect and plasma level of phenylbutazone was demonstrated. 4. Some problems in the interpretation of plasma level-clinical effect correlates are discussed.

PMID:
786356
PMCID:
PMC1402615
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Support Center